home / stock / reph / reph news

REPH News and Press, Recro Pharma Inc. From 05/10/23

Stock Information
Company Name: Recro Pharma Inc.
Stock Symbol: REPH
Market: NASDAQ
Website: recropharma.com
Menu
REPH REPH Quote REPH Short REPH News REPH Articles REPH Message Board
Get REPH Alerts

News, Short Squeeze, Breakout and More Instantly...
REPH - Societal CDMO Reports First Quarter 2023 Financial Results

Recorded Q1 Revenue of $21.5 Million Signed Multiple New Business Agreements with New and Existing Customers Granted FDA Approval for Manufacture of First Commercial Tablet Product Company to Host Webcast Today at 4:30 p.m. ET SAN DIEGO and GAINESVILLE, Ga., May 10...
REPH - Societal CDMO to Participate in RBC Capital Markets Global Healthcare Conference

SAN DIEGO and GAINESVILLE, Ga., May 09, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: SCTL ), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges pri...

REPH - Societal CDMO Selected by Xequel Bio to Provide CDMO Services to Support Ongoing Clinical Development of iNexin(TM)

SAN DIEGO and GAINESVILLE, Ga., May 08, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASD: SCTL ), a contract development and manufacturing organization (CDMO), today announced that it has been selected by Xequel Bio, Inc. (“Xequel”) to provide CD...

REPH - Societal CDMO to Report Financial Results for First Quarter 2023 on May 10, 2023

SAN DIEGO and GAINESVILLE, Ga., May 03, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: SCTL ), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges pri...
REPH - Societal CDMO Signs Multiple Project Expansion Agreements With Existing Customers

SAN DIEGO and GAINESVILLE, Ga., April 12, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASD: SCTL ), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule t...

REPH - Societal CDMO Selected by Longboard Pharmaceuticals to Provide CDMO Services to Support Clinical Development of LP352

SAN DIEGO and GAINESVILLE, Ga., April 05, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASD: SCTL ), a contract development and manufacturing organization (CDMO), today announced that it has been selected by Longboard Pharmaceuticals, Inc. (NASD: ...

REPH - Societal CDMO Announces U.S. FDA Approval for Manufacturing of Commercial Tablet at Gainesville, Georgia Site

SAN DIEGO, Calif. and GAINESVILLE, Ga., March 20, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: SCTL ), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing chal...
REPH - Societal CDMO to Participate at 35th Annual Roth Conference

SAN DIEGO and GAINESVILLE, Ga., March 03, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: SCTL ), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges p...

REPH - Societal CDMO Reports Fourth Quarter and Full Year 2022 Financial Results

Recorded Q4 Revenue of $24.3 Million, a 9% Increase Compared to Prior Year Period Clinical Trial Materials Development Business Grew by 58% in 2022; Significantly Expanded and Diversified Customer Base Executed Multi-Step Strategy Resulting in Reduction of Debt and Strengthened ...

REPH - Societal CDMO to Report Financial Results for Fourth Quarter and Year-End 2022 on March 1, 2023

Webcast Scheduled for Wednesday, March 1, 2023, at 4:30 p.m. Eastern SAN DIEGO and GAINESVILLE, Ga., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: SCTL ), a contract development and manufacturing organization (CDM...
Previous 10 Next 10